Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) ; 46(6): 415-424, sept. 2020. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-200415

RESUMO

La prevalencia de la diabetes tipo 2 diagnosticada en la infancia/juventud está aumentando y se caracteriza por una disminución acelerada de la función de las células beta pancreáticas y resistencia a la insulina. Los principales factores de riesgo para su desarrollo son obesidad e inactividad física. Los criterios diagnósticos son similares a los utilizados en adultos, aunque la HbA1c como método diagnóstico está cuestionada. Las complicaciones son más agresivas que en la diabetes tipo 2 del adulto, siendo la nefropatía la más frecuente. Las complicaciones macrovasculares aparecen precozmente y su mortalidad es elevada. La alimentación saludable y el ejercicio físico continuado son los pilares básicos del tratamiento, y la metformina, insulina y liraglutide (aprobado por la FDA en Estados Unidos) las opciones farmacológicas con indicación en esta población. Es importante establecer modelos de transición de la atención pediátrica a la atención adulta para garantizar la continuidad asistencial y evitar pérdidas en el seguimiento de estos pacientes


The prevalence of type 2 diabetes (DM2) diagnosed in childhood and adolescence is currently increasing, and is characterised by a rapidly progressive decline in beta-cells and insulin resistance. Physical inactivity and obesity are the main risk factors for its development. Diagnostic criteria are similar to those used in adults, although HbA1c as a diagnostic method is questioned. Diabetes-related complications are more aggressive than in adults. Diabetic nephropathy is the most frequent complication in the young population and macrovascular complications appear early, leading to high mortality rates. Healthy lifestyles are the basis of the treatment, and metformin, insulin and liraglutide (approved by FDA for its use in the United States) are the pharmacological options indicated in this population. It is important to establish models of health care transition from paediatric to adult care to ensure continuity of care and avoid patient disengagements


Assuntos
Humanos , Diabetes Mellitus Tipo 2/terapia , Obesidade/epidemiologia , Comportamento Sedentário , Nefropatias Diabéticas/epidemiologia , Síndrome Metabólica/epidemiologia , Fatores de Risco , Diabetes Mellitus Tipo 2/epidemiologia , Complicações do Diabetes/epidemiologia , Hemoglobinas Glicadas/análise , Atenção Primária à Saúde/tendências , Estilo de Vida Saudável/classificação , Metformina/uso terapêutico , Adolescente , Adulto Jovem/estatística & dados numéricos
2.
Semergen ; 46(6): 415-424, 2020 Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-32094051

RESUMO

The prevalence of type 2 diabetes (DM2) diagnosed in childhood and adolescence is currently increasing, and is characterised by a rapidly progressive decline in beta-cells and insulin resistance. Physical inactivity and obesity are the main risk factors for its development. Diagnostic criteria are similar to those used in adults, although HbA1c as a diagnostic method is questioned. Diabetes-related complications are more aggressive than in adults. Diabetic nephropathy is the most frequent complication in the young population and macrovascular complications appear early, leading to high mortality rates. Healthy lifestyles are the basis of the treatment, and metformin, insulin and liraglutide (approved by FDA for its use in the United States) are the pharmacological options indicated in this population. It is important to establish models of health care transition from paediatric to adult care to ensure continuity of care and avoid patient disengagements.


Assuntos
Diabetes Mellitus Tipo 2 , Transição para Assistência do Adulto , Adolescente , Diabetes Mellitus Tipo 2/terapia , Humanos , Insulina , Metformina , Atenção Primária à Saúde , Estados Unidos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...